AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11426363 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine management including collection of autologous blood)
Number of subjects: 60
Study 9276107 — intervention group
Group type: EXPERIMENTAL
Intervention: Left vagal nerve stimulation (VNS)
Number of subjects: 10
Study 7643542 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment (AHT) - angiotensin converting enzyme inhibition for 6 (2 to 15) years
Number of subjects: 42
Study 2745908 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-Setting/Goal Attainment group (GSGA, n=19)
Number of subjects: 60
Study 2745908 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-Setting group (GS, n=19)
Number of subjects: 60
Study 2745908 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=22)
Number of subjects: 60
Study 336305 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized fenoterol 400 microgram
Number of subjects: 31
Study 336305 — intervention group
Group type: COMPARATOR
Intervention: Isoproterenol 150 microgram
Number of subjects: 31
Study 30812036 — intervention group
Group type: EXPERIMENTAL
Intervention: No mechanical bowel preparation (MBP)
Number of subjects: 80
Study 30812036 — intervention group
Group type: COMPARATOR
Intervention: Routine mechanical bowel preparation (MBP)
Number of subjects: 80
Study 28153510 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical pudendal nerve stimulation
Number of subjects: 120
Study 28153510 — intervention group
Group type: COMPARATOR
Intervention: Transvaginal electrical stimulation
Number of subjects: 120
Study 24317122 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention starting 2 weeks before admission and ending 6-8 weeks after discharge.
Number of subjects: 105
Study 22874485 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin converting enzyme inhibitors (ACEIs)
Number of subjects: 124
Study 22874485 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretics
Number of subjects: 124
Study 22874485 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study 20090327 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin infiltration followed by fluoride varnish (2.26% F) application
Number of subjects: 50
Study 20090327 — intervention group
Group type: COMPARATOR
Intervention: Fluoride varnish only
Number of subjects: 50
Study 18559556 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin 10 g
Number of subjects: 12
Study 18559556 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin 12 g
Number of subjects: 12
Study 16176340 — intervention group
Group type: EXPERIMENTAL
Intervention: Landiolol (short‐acting beta‐1‐adrenergic blocker)
Number of subjects: 40
Study 16176340 — intervention group
Group type: COMPARATOR
Intervention: Control (0.9% saline)
Number of subjects: 40
Study 12639033 — intervention group
Group type: EXPERIMENTAL
Intervention: Household water chlorination and storage in a special container
Number of subjects: 0
Study 12639033 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 0
Study 10480199 — intervention group
Group type: EXPERIMENTAL
Intervention: Family strategies intervention
Number of subjects: 87
Study 8562214 — intervention group
Group type: EXPERIMENTAL
Intervention: Por La Vida intervention
Number of subjects: 512
Study 8562214 — intervention group
Group type: COMPARATOR
Intervention: Community Living Skills (Control)
Number of subjects: 512
Study 2118879 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 micrograms IFN-gamma
Number of subjects: 5
Study 2118879 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 micrograms IFN-gamma
Number of subjects: 5
Study 2118879 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 micrograms IFN-gamma
Number of subjects: 5
Study 2118879 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated application of the same dose
Number of subjects: 5
Study 2118879 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in TNF serum levels
Number of subjects: 5
Study 626496 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacampicillin
Number of subjects: 11
Study 626496 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivampicillin
Number of subjects: 11
Study 626496 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin
Number of subjects: 11
Study 626496 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 11
Study 626496 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacampicillin and Pivampicillin
Number of subjects: 11
Study 31957922 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 100 U
Number of subjects: 248
Study 31957922 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248
Study 31759966 — intervention group
Group type: EXPERIMENTAL
Intervention: LAMA-LABA-ICS
Number of subjects: 8853
Study 31759966 — intervention group
Group type: COMPARATOR
Intervention: LAMA-LABA
Number of subjects: 8853
Study 27930924 — intervention group
Group type: EXPERIMENTAL
Intervention: Radium-223
Number of subjects: 881
Study 27930924 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 881
Study 25550349 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral amoxicillin
Number of subjects: 527
Study 25550349 — intervention group
Group type: COMPARATOR
Intervention: Benzyl penicillin
Number of subjects: 527
Study 25550349 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mortality
Number of subjects: 527
Study 25550349 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of wheeze
Number of subjects: 527
Study 23758661 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 minutes of daily progressive resistance training with elastic tubing
Number of subjects: 198
Study 23758661 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 minutes of daily progressive resistance training with elastic tubing
Number of subjects: 198
Study 23758661 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving weekly information on general health
Number of subjects: 198
Study 19858350 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention (self-selected music of 60-80 beats per minute for 30 minutes)
Number of subjects: 72
Study 19858350 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation (PMR) intervention (pre-recorded audio of instructions for 16 muscle groups)
Number of subjects: 72
Study 19858350 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 72
Study 17093146 — intervention group
Group type: EXPERIMENTAL
Intervention: Lupin kernel flour-enriched bread (LB) breakfast
Number of subjects: 33
Study 17093146 — intervention group
Group type: EXPERIMENTAL
Intervention: Lupin kernel flour-enriched bread (LB) lunch
Number of subjects: 33
Study 17093146 — intervention group
Group type: COMPARATOR
Intervention: White bread (WB) breakfast
Number of subjects: 33
Study 17093146 — intervention group
Group type: COMPARATOR
Intervention: White bread (WB) lunch
Number of subjects: 33
Study 14985224 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 micro g folic acid
Number of subjects: 144
Study 14985224 — intervention group
Group type: EXPERIMENTAL
Intervention: 416 micro g [6S]-5-MTHF
Number of subjects: 144
Study 14985224 — intervention group
Group type: EXPERIMENTAL
Intervention: 208 micro g [6S]-5-MTHF
Number of subjects: 144
Study 14985224 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study 11134430 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant granulocyte colony-stimulating factor (rG-CSF) 10 microgram/kg/day IV once daily for 3 days
Number of subjects: 44
Study 11134430 — intervention group
Group type: COMPARATOR
Intervention: Placebo (visually indistinguishable vehicle)
Number of subjects: 44
Study 11134430 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant granulocyte colony-stimulating factor (rG-CSF)
Number of subjects: 44
Study 9253572 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiseptic-impregnated catheter (silver sulphadiazine and chlorhexidine)
Number of subjects: 79
Study 9253572 — intervention group
Group type: COMPARATOR
Intervention: Standard polyurethane catheter
Number of subjects: 79
Study 8487664 — intervention group
Group type: EXPERIMENTAL
Intervention: ACIPIMOX
Number of subjects: 10
Study 8487664 — intervention group
Group type: EXPERIMENTAL
Intervention: HEPARIN
Number of subjects: 10
Study 8487664 — intervention group
Group type: COMPARATOR
Intervention: NIL
Number of subjects: 10
Study 2887951 — intervention group
Group type: EXPERIMENTAL
Intervention: octreotide (SMS 201-995)
Number of subjects: 14
Study 2887951 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14
Study 29392419 — intervention group
Group type: EXPERIMENTAL
Intervention: Growing steers (n = 6)
Number of subjects: 8
Study 29392419 — intervention group
Group type: COMPARATOR
Intervention: Finished steers (n = 4)
Number of subjects: 8
Study 27143350 — intervention group
Group type: EXPERIMENTAL
Intervention: Health coaching intervention
Number of subjects: 0
Study 27143350 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 0
Study 24439136 — intervention group
Group type: EXPERIMENTAL
Intervention: Tigecycline (150 mg once-daily)
Number of subjects: 944
Study 24439136 — intervention group
Group type: COMPARATOR
Intervention: Ertapenem ± vancomycin (1 g once-daily)
Number of subjects: 944
Study 23011489 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month, 3 times per week exercise intervention
Number of subjects: 140
Study 20729688 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-pressure (8 mm Hg)
Number of subjects: 60
Study 20729688 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-pressure (12 mm Hg)
Number of subjects: 60
Study 20729688 — intervention group
Group type: EXPERIMENTAL
Intervention: High-pressure (14 mm Hg)
Number of subjects: 60
Study 19128258 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical basic fibroblast growth factor (bFGF)
Number of subjects: 0
Study 15735613 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-release metoprolol
Number of subjects: 80
Study 12525515 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery plus fluorouracil (FU)-leucovorin chemotherapy (431 patients)
Number of subjects: 706
Study 12525515 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (275 patients)
Number of subjects: 706
Study 11012951 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental presence during anaesthesia induction
Number of subjects: 73
Study 8780417 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine (200 mg daily)
Number of subjects: 41
Study 8780417 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 1363375 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg of propranolol
Number of subjects: 28
Study 1363375 — intervention group
Group type: COMPARATOR
Intervention: 30 mg of diazepam
Number of subjects: 28
Study 6469178 — intervention group
Group type: EXPERIMENTAL
Intervention: Trigastril 50 Del
Number of subjects: 6
Study 6469178 — intervention group
Group type: EXPERIMENTAL
Intervention: Maaloxan Suspension
Number of subjects: 6
Study 6469178 — intervention group
Group type: EXPERIMENTAL
Intervention: Kompensan‐S forte Suspension
Number of subjects: 6
Study 6469178 — intervention group
Group type: EXPERIMENTAL
Intervention: Solugastril 50 Gel
Number of subjects: 6
Study 31414586 — intervention group
Group type: COMPARATOR
Intervention: Metabolically unhealthy obese (MUO) group
Number of subjects: 301
Study 31414586 — intervention group
Group type: COMPARATOR
Intervention: Metabolically healthy obese (MHO) group
Number of subjects: 301
Study 29318917 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (20-minute session) combined with manual therapy (15-minute session) and therapeutic exercise (15-minute session)
Number of subjects: 43
Study 29318917 — intervention group
Group type: COMPARATOR
Intervention: Inspiratory muscle training (20-minute session)
Number of subjects: 43
Study 27390979 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine (35 mg tablet/twice daily for 4 days)
Number of subjects: 40
Study 27390979 — intervention group
Group type: COMPARATOR
Intervention: Control group (no trimetazidine)
Number of subjects: 40
Study 24974847 — intervention group
Group type: EXPERIMENTAL
Intervention: TANC1 locus
Number of subjects: 741
Study 22124605 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance-type exercise (75% one repetition maximum)
Number of subjects: 45
Study 22124605 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance-type exercise (50% maximum workload capacity)
Number of subjects: 45
Study 19579590 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative serum levels of TPA (cut off level = 53 IU/L) after liver resection
Number of subjects: 173
Study 19579590 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative serum levels of TPS (cut off level = 81 IU/L) after liver resection
Number of subjects: 173
Study 19579590 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative serum levels of TPA after RFA
Number of subjects: 173
Study 19579590 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative serum levels of TPS after RFA
Number of subjects: 173
Study 17505265 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha2b 10 million units/m(2) subcutaneously three times a week plus rh-Endostatin 45 mg/m(2) subcutaneously every 12 h (arm A)
Number of subjects: 21
Study 17505265 — intervention group
Group type: COMPARATOR
Intervention: rh-Endostatin alone (arm B)
Number of subjects: 21
Study 15370023 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine treatment in a specialist clinic
Number of subjects: 115
Study 15370023 — intervention group
Group type: COMPARATOR
Intervention: Buprenorphine treatment in a shared care setting
Number of subjects: 115
Study 11462292 — intervention group
Group type: EXPERIMENTAL
Intervention: SonoVue (0.3, 0.6, 1.2, and 2.4 mL intravenous bolus injection)
Number of subjects: 40
Study 9740292 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium stibogluconate at a dose of 20 mg/kg/day for 20 days (group A)
Number of subjects: 54
Study 9740292 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium stibogluconate at a dose of 20 mg/kg/day for 30 days (group B)
Number of subjects: 54
Study 8058855 — intervention group
Group type: EXPERIMENTAL
Intervention: TV news program designed to expose myths about NGRI
Number of subjects: 50
Study 8058855 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief factual report about NGRI
Number of subjects: 50
Study 8058855 — intervention group
Group type: COMPARATOR
Intervention: Neutral program
Number of subjects: 50
Study 2972756 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg diazepam
Number of subjects: 10
Study 2972756 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg diazepam
Number of subjects: 10
Study 2972756 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline)
Number of subjects: 10
Study 2972756 — intervention group
Group type: COMPARATOR
Intervention: Control (painful stimulation)
Number of subjects: 10
Study 28712467 — intervention group
Group type: EXPERIMENTAL
Intervention: Antisocial in-group paired with prosocial out-group
Number of subjects: 2
Study 28712467 — intervention group
Group type: EXPERIMENTAL
Intervention: Antisocial in-group paired with antisocial out-group
Number of subjects: 2
Study 28712467 — intervention group
Group type: COMPARATOR
Intervention: Control group (younger children)
Number of subjects: 2
Study 28712467 — intervention group
Group type: EXPERIMENTAL
Intervention: Resource allocation behavior
Number of subjects: 2
Study 27044854 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 70 mg/kg
Number of subjects: 8
Study 27044854 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 8
Study 27044854 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 8
Study 25006914 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS)
Number of subjects: 60
Study 25006914 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 23986157 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% alpha-hydroxy/polyhydroxy acid emollient
Number of subjects: 25
Study 23986157 — intervention group
Group type: COMPARATOR
Intervention: 6% salicylic acid cream
Number of subjects: 25
Study 20349368 — intervention group
Group type: EXPERIMENTAL
Intervention: Visibly-descriptive names
Number of subjects: 52
Study 20349368 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychologically-descriptive names
Number of subjects: 52
Study 20349368 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-descriptive names
Number of subjects: 52
Study 20349368 — intervention group
Group type: EXPERIMENTAL
Intervention: Visibly-descriptive names for older adults
Number of subjects: 52
Study 20349368 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychologically-descriptive names for older adults
Number of subjects: 52
Study 20349368 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-descriptive names for older adults
Number of subjects: 52
Study 18754533 — intervention group
Group type: EXPERIMENTAL
Intervention: Low power laser (LPL) therapy (9‐11 joules/cm2) over the carpal tunnel area
Number of subjects: 80
Study 18754533 — intervention group
Group type: COMPARATOR
Intervention: Sham laser therapy
Number of subjects: 80
Study 15948202 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear-EIM in patients with radiculopathy
Number of subjects: 20
Study 15948202 — intervention group
Group type: COMPARATOR
Intervention: Linear-EIM in normal subjects
Number of subjects: 20
Study 12911781 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific immunotherapy (SIT) with Alutard(R)‐SQ, Dermatophagoides pteronyssinus extract, administered with increasing doses until maintenance dose reached, then once a month for 12 months.
Number of subjects: 36
Study 12911781 — intervention group
Group type: COMPARATOR
Intervention: Placebo preparation, identical to the active preparation.
Number of subjects: 36
Study 10575594 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg ipriflavone orally daily
Number of subjects: 30
Study 10575594 — intervention group
Group type: COMPARATOR
Intervention: 20 units elcatonin, weekly injected intramuscularly
Number of subjects: 30
Study 10575594 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of bone gainers with increase of lumbar spine BMD by 2% or more with bone losers with a decrease by 2% or more
Number of subjects: 30
Study 8767354 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg effervescent tablet
Number of subjects: 24
Study 8767354 — intervention group
Group type: COMPARATOR
Intervention: Al-Mg-hydroxide 10 ml
Number of subjects: 24
Study 8767354 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 1901321 — intervention group
Group type: EXPERIMENTAL
Intervention: Fleroxacin (600 mg/d for 72 hours)
Number of subjects: 18
Study 1901321 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 1901321 — intervention group
Group type: EXPERIMENTAL
Intervention: Fleroxacin
Number of subjects: 18
Study 7125177 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg morphine base (2.63 mg morphine hydrochloride) in 10 ml 0.9% sodium chloride
Number of subjects: 60
Study 7125177 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg morphine base in 10 ml 5% glucose
Number of subjects: 60
Study 7125177 — intervention group
Group type: COMPARATOR
Intervention: 10 ml 5% glucose as placebo
Number of subjects: 60
Study 30651127 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological mesh
Number of subjects: 496
Study 30651127 — intervention group
Group type: COMPARATOR
Intervention: Synthetic mesh
Number of subjects: 496
Study 27775992 — intervention group
Group type: EXPERIMENTAL
Intervention: rAd‐p53+CRT
Number of subjects: 162
Study 27775992 — intervention group
Group type: COMPARATOR
Intervention: CRT
Number of subjects: 162
Study 27775992 — intervention group
Group type: COMPARATOR
Intervention: rAd‐p53
Number of subjects: 162
Study 25454363 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-piece IOL (Tecnis ZCB00)
Number of subjects: 50
Study 25454363 — intervention group
Group type: COMPARATOR
Intervention: 3-piece IOL (Tecnis ZA9003)
Number of subjects: 50
Study 23634982 — intervention group
Group type: EXPERIMENTAL
Intervention: ProActive Heart intervention (telephone-based health coaching)
Number of subjects: 430
Study 23634982 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 430
Study 21494226 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate Diet (LCD)
Number of subjects: 270
Study 21494226 — intervention group
Group type: COMPARATOR
Intervention: Low-Fat Diet (LFD)
Number of subjects: 270
Study 19524752 — intervention group
Group type: EXPERIMENTAL
Intervention: Real interferential therapy (IFT), 12 sessions for 4 weeks
Number of subjects: 33
Study 19524752 — intervention group
Group type: COMPARATOR
Intervention: Placebo interferential therapy (IFT), 12 sessions for 4 weeks
Number of subjects: 33
Study 16087140 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic beta-blockade with carvedilol or metoprolol
Number of subjects: 19
Study 14616423 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual cobalamin (500 micro g daily)
Number of subjects: 30
Study 14616423 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cobalamin (500 micro g daily)
Number of subjects: 30
Study 14616423 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin B complex (two tablets daily)
Number of subjects: 30
Study 10977385 — intervention group
Group type: EXPERIMENTAL
Intervention: Torasemide
Number of subjects: 193
Study 10977385 — intervention group
Group type: COMPARATOR
Intervention: Furosemide
Number of subjects: 193
Study 9038554 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous postoperative femoral nerve block with 0.5% bupivacaine (5 ml/h for 48 h) plus PCA with morphine
Number of subjects: 20
Study 9038554 — intervention group
Group type: COMPARATOR
Intervention: Control group using PCA device alone
Number of subjects: 20
Study 1824621 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal laser angioplasty (PTLA) followed by balloon dilatation
Number of subjects: 167
Study 1824621 — intervention group
Group type: COMPARATOR
Intervention: Long-term treatment with phenprocumarol
Number of subjects: 167
Study 1824621 — intervention group
Group type: COMPARATOR
Intervention: Long-term treatment with acetylsalicylic acid (ASA) plus dipyridamole
Number of subjects: 167